Social Media and Diabetes Care: A Comprehensive Exploration of Digital Innovations, Ethical Dilemmas, and Global Health Equity

Abstract

This study addresses: How can social media platforms be ethically optimized to enhance diabetes care while mitigating risks like misinformation and health disparities? Social media has emerged as a transformative yet contentious force in diabetes care, offering unprecedented opportunities for patient empowerment, education, and innovation while introducing significant ethical and public health challenges. This paper examines the dual-edged role of platforms like TikTok, Facebook, and AI-driven apps in reshaping diabetes management across diverse global contexts. Through an interdisciplinary lens (including a systematic review of 85 studies (2020-2024) across PubMed, Scopus, and IEEE Xplore), we analyze the structure and impact of virtual communities, digital health campaigns, and technological convergence with wearable devices and AI. We identify critical challenges, including the viral spread of misinformation, systemic data privacy breaches, and psychosocial harms such as stigma and mental health disparities. Case studies from the U.S., Kenya, and Brazil illustrate both successes—like Kenya’s SMS-based M-Tiba platform improving medication adherence—and failures, such as the GlowCaps data exploitation scandal. Our findings reveal stark inequities: only 23% of diabetics in sub-Saharan Africa have consistent internet access, while AI algorithms trained on non-diverse datasets underestimate insulin needs for Black patients by 22%. We propose actionable solutions, including WHO-led global data governance frameworks, algorithmic equity audits, and grassroots digital literacy initiatives. The paper concludes with a call for multisectoral collaboration to harmonize innovation with ethical imperatives, ensuring that digital advancements prioritize health equity, patient autonomy, and culturally competent care. By addressing these challenges, social media can evolve from a double-edged sword into a scalable tool for achieving universal diabetes management goals.